Genetic Risk Factors for Portopulmonary Hypertension in Patients with Advanced Liver Disease
Kari E. Roberts(Tufts Medical Center), Steven M. Kawut(Hospital of the University of Pennsylvania), Neil Kaplowitz(University of Southern California), Evelyn M. Horn(Cornell University), Inga Peter(Icahn School of Medicine at Mount Sinai), David B. Badesch(University of Colorado Anschutz Medical Campus), Michael B. Fallon(University of Arizona), Hocine Tighiouart(Tufts University), Steven Zacks(University of North Carolina at Chapel Hill), Raymond L. Benza(Triangle), Darren B. Taichman(University of Pennsylvania), Robert S. Brown(Cornell University), James F. Trotter(Baylor Scott & White Health), Daniel Rabinowitz(Columbia University), James A. Knowles(Rutgers, The State University of New Jersey), Michael J. Krowka(Mayo Clinic)
American Journal of Respiratory and Critical Care Medicine
February 12, 2009
Cited by 232
Related Papers
Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C
|New England Journal of Medicine|2012|4.1k
Clinical Characteristics of Covid-19 in New York City
|New England Journal of Medicine|2020|2.4k
Definitions and Diagnosis of Pulmonary Hypertension
|Journal of the American College of Cardiology|2013|1.8k
Predicting Survival in Pulmonary Arterial Hypertension
|Circulation|2010|1.5k